Filing Details

Accession Number:
0001140361-18-009972
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-02-23 20:39:16
Reporting Period:
2018-02-21
Accepted Time:
2018-02-23 20:39:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1301501 Achaogen Inc AKAO Pharmaceutical Preparations (2834) 680533693
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1654446 Blake Wise C/O Achaogen, Inc.
1 Tower Place #300
South San Francisco CA 94080
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-02-21 1,640 $10.67 65,645 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 178,416 Indirect See Footnote
Footnotes
  1. The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of Restricted Stock Units of the Issuer.
  2. Includes (i) 1,174 shares acquired under the issuer's Employee Stock Purchase Plan on November 30, 2017 and (ii) 39,700 Restricted Stock Units.
  3. The shares are held directly by the Blake A. Wise Living Trust.